EC: 1.3.1.3
DELTA4-3-oxosteroid 5beta-reductase (5beta-cholestan-3-one:NADP+ 4,5-oxidoreductase)
Pathways
| pathway id | name |
|---|---|
| BioCyc:META_PWY-6032 | cardenolide biosynthesis |
| PlantCyc:PLANT_PWY-6032 | cardenolide biosynthesis |
| Reactome:R-HSA-194068 | Bile acid and bile salt metabolism |
| Reactome:R-HSA-193807 | Synthesis of bile acids and bile salts via 27-hydroxycholesterol |
| Reactome:R-MMU-1430728 | Metabolism |
| Reactome:R-MMU-556833 | Metabolism of lipids |
| Reactome:R-MMU-8957322 | Metabolism of steroids |
| Reactome:R-MMU-193775 | Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| Reactome:R-RNO-193368 | Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| Reactome:R-HSA-556833 | Metabolism of lipids |
| Reactome:R-HSA-193775 | Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| Reactome:R-MMU-193368 | Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| Reactome:R-RNO-192105 | Synthesis of bile acids and bile salts |
| Reactome:R-HSA-192105 | Synthesis of bile acids and bile salts |
| Reactome:R-MMU-194068 | Bile acid and bile salt metabolism |
| Reactome:R-MMU-193807 | Synthesis of bile acids and bile salts via 27-hydroxycholesterol |
| Reactome:R-RNO-1430728 | Metabolism |
| Reactome:R-RNO-556833 | Metabolism of lipids |
| Reactome:R-RNO-8957322 | Metabolism of steroids |
| Reactome:R-RNO-193775 | Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| Reactome:R-HSA-1430728 | Metabolism |
| Reactome:R-HSA-8957322 | Metabolism of steroids |
| Reactome:R-HSA-193368 | Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| Reactome:R-MMU-192105 | Synthesis of bile acids and bile salts |
| Reactome:R-RNO-194068 | Bile acid and bile salt metabolism |
| Reactome:R-RNO-193807 | Synthesis of bile acids and bile salts via 27-hydroxycholesterol |
| WikiPathways:WP5280 | Glucocorticoid biosynthesis |
| PathBank:SMP0120658 | 17-beta Hydroxysteroid Dehydrogenase III Deficiency |
| PathBank:SMP0120690 | Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH |
| PathBank:SMP0120858 | 11-beta-Hydroxylase Deficiency (CYP11B1) |
| PathBank:SMP0030406 | Androstenedione Metabolism |
| PathBank:SMP0000068 | Androgen and Estrogen Metabolism |
| PathBank:SMP0000373 | Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency |
| PathBank:SMP0000318 | Congenital Bile Acid Synthesis Defect Type III |
| PathBank:SMP0000576 | 21-Hydroxylase Deficiency (CYP21) |
| PathBank:SMP0000718 | 3-beta-Hydroxysteroid Dehydrogenase Deficiency |
| PathBank:SMP0120697 | Familial Hypercholanemia (FHCA) |
| PathBank:SMP0120849 | 17-alpha-Hydroxylase Deficiency (CYP17) |
| PathBank:SMP0120861 | Corticosterone Methyl Oxidase II Deficiency (CMO II) |
| PathBank:SMP0120869 | 3-beta-Hydroxysteroid Dehydrogenase Deficiency |
| PathBank:SMP0000035 | Bile Acid Biosynthesis |
| PathBank:SMP0000356 | 17-beta Hydroxysteroid Dehydrogenase III Deficiency |
| PathBank:SMP0000314 | Congenital Bile Acid Synthesis Defect Type II |
| PathBank:SMP0000315 | Cerebrotendinous Xanthomatosis (CTX) |
| PathBank:SMP0000575 | 11-beta-Hydroxylase Deficiency (CYP11B1) |
| PathBank:SMP0000717 | Apparent Mineralocorticoid Excess Syndrome |
| PathBank:SMP0087329 | Bile Acid Biosynthesis |
| PathBank:SMP0120672 | Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency |
| PathBank:SMP0120688 | Congenital Bile Acid Synthesis Defect Type III |
| PathBank:SMP0120848 | Aromatase Deficiency |
| PathBank:SMP0120860 | Corticosterone Methyl Oxidase I Deficiency (CMO I) |
| PathBank:SMP0120868 | Apparent Mineralocorticoid Excess Syndrome |
| PathBank:SMP0000130 | Steroidogenesis |
| PathBank:SMP0000371 | Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH |
| PathBank:SMP0000317 | Familial Hypercholanemia (FHCA) |
| PathBank:SMP0000565 | Aromatase Deficiency |
| PathBank:SMP0000577 | Corticosterone Methyl Oxidase I Deficiency (CMO I) |
| PathBank:SMP0087344 | Androgen and Estrogen Metabolism |
| PathBank:SMP0087364 | Androstenedione Metabolism |
| PathBank:SMP0120671 | Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency |
| PathBank:SMP0120683 | Cerebrotendinous Xanthomatosis (CTX) |
| PathBank:SMP0120687 | Congenital Bile Acid Synthesis Defect Type II |
| PathBank:SMP0120715 | Zellweger Syndrome |
| PathBank:SMP0120859 | 21-Hydroxylase Deficiency (CYP21) |
| PathBank:SMP0120871 | 27-Hydroxylase Deficiency |
| PathBank:SMP0000372 | Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency |
| PathBank:SMP0000316 | Zellweger Syndrome |
| PathBank:SMP0000566 | 17-alpha-Hydroxylase Deficiency (CYP17) |
| PathBank:SMP0000578 | Corticosterone Methyl Oxidase II Deficiency (CMO II) |
| PathBank:SMP0000720 | 27-Hydroxylase Deficiency |
| PathBank:SMP0087331 | Steroidogenesis |